ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 227 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,768,617 | +62.5% | 108,838 | +85.0% | 0.00% | +50.0% |
| Q1 2024 | $1,088,063 | -76.4% | 58,846 | -60.0% | 0.00% | -75.0% |
| Q4 2023 | $4,605,669 | +76.7% | 147,099 | +17.6% | 0.01% | +60.0% |
| Q3 2023 | $2,606,896 | +186.6% | 125,091 | +229.4% | 0.01% | +400.0% |
| Q2 2023 | $909,621 | -45.7% | 37,980 | -57.3% | 0.00% | -66.7% |
| Q1 2023 | $1,675,149 | +1026.7% | 89,009 | +853.1% | 0.00% | – |
| Q4 2022 | $148,676 | -23.0% | 9,339 | -21.2% | 0.00% | – |
| Q3 2022 | $193,000 | +16.3% | 11,852 | +0.5% | 0.00% | – |
| Q2 2022 | $166,000 | -89.0% | 11,794 | -81.1% | 0.00% | -100.0% |
| Q1 2022 | $1,507,000 | +9.7% | 62,260 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $1,374,000 | – | 58,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |